FI871327A - Ny optiskt aktiv foerening. - Google Patents

Ny optiskt aktiv foerening. Download PDF

Info

Publication number
FI871327A
FI871327A FI871327A FI871327A FI871327A FI 871327 A FI871327 A FI 871327A FI 871327 A FI871327 A FI 871327A FI 871327 A FI871327 A FI 871327A FI 871327 A FI871327 A FI 871327A
Authority
FI
Finland
Prior art keywords
foerening
optical active
active
optical
active foerening
Prior art date
Application number
FI871327A
Other languages
English (en)
Finnish (fi)
Other versions
FI871327A0 (fi
Inventor
Hermann Amschler
Bernhard Kohl
Manfrid Eltze
Dieter Flockerzi
Kurt Klemm
Norbert Kolassa
Karl Sanders
Christian Schudt
Wolf-Ruediger Ulrich
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of FI871327A0 publication Critical patent/FI871327A0/fi
Publication of FI871327A publication Critical patent/FI871327A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI871327A 1986-03-27 1987-03-26 Ny optiskt aktiv foerening. FI871327A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH126386 1986-03-27

Publications (2)

Publication Number Publication Date
FI871327A0 FI871327A0 (fi) 1987-03-26
FI871327A true FI871327A (fi) 1987-09-28

Family

ID=4206306

Family Applications (1)

Application Number Title Priority Date Filing Date
FI871327A FI871327A (fi) 1986-03-27 1987-03-26 Ny optiskt aktiv foerening.

Country Status (12)

Country Link
EP (1) EP0240828A1 (da)
JP (1) JPS62270528A (da)
KR (1) KR870008872A (da)
CN (1) CN87102402A (da)
AU (1) AU574604B2 (da)
DK (1) DK142287A (da)
FI (1) FI871327A (da)
HU (1) HU196791B (da)
NO (1) NO871284L (da)
NZ (1) NZ219779A (da)
PT (1) PT84566B (da)
ZA (1) ZA872189B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3883627D1 (de) * 1987-03-27 1993-10-07 Byk Gulden Lomberg Chem Fab 1,4-Dihydropyridin-Enantiomere.
HU206181B (en) * 1988-02-19 1992-09-28 Byk Gulden Lomberg Chem Fab Process for producing pharmaceutical compositions comprising optically pure r-(+)-niguldipin and its derivatives and suitable for treating tumoros diseases
DE4125271A1 (de) * 1991-07-31 1993-02-11 Bayer Ag Neue n-alkylierte 1,4-dihydropyridindicarbonsaeureester
US6015819A (en) 1992-11-13 2000-01-18 Synaptic Pharmaceutical Corporation Use of alpha-1C specific compounds to treat benign prostatic hyperplasia
GB9405833D0 (en) * 1994-03-24 1994-05-11 Pfizer Ltd Separation of the enantiomers of amlodipine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
US4603135A (en) * 1983-10-17 1986-07-29 Takeda Chemical Industries, Ltd. Substituted piperazinyl alkyl esters of 2-amino-4-aryl-1,4-dihydro-6-alkyl-3,5-pyridinedicarboxylates
FI83957C (fi) * 1984-09-28 1991-09-25 Byk Gulden Lomberg Chem Fab Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara diarylfoereningar.
DK114587A (da) * 1986-03-12 1987-09-13 Byk Gulden Lomberg Chem Fab Monocycliske esterderivater

Also Published As

Publication number Publication date
HUT43588A (en) 1987-11-30
NO871284L (no) 1987-09-28
DK142287A (da) 1987-09-28
AU7052587A (en) 1987-12-10
DK142287D0 (da) 1987-03-19
HU196791B (en) 1989-01-30
JPS62270528A (ja) 1987-11-24
AU574604B2 (en) 1988-07-07
CN87102402A (zh) 1987-10-07
NZ219779A (en) 1990-03-27
EP0240828A1 (de) 1987-10-14
PT84566A (de) 1987-04-01
ZA872189B (en) 1987-11-25
FI871327A0 (fi) 1987-03-26
KR870008872A (ko) 1987-10-21
NO871284D0 (no) 1987-03-26
PT84566B (pt) 1989-11-30

Similar Documents

Publication Publication Date Title
ES2021040B3 (es) Aspirador-irrigador oftalmico.
DE3768052D1 (de) Optisch aktive adsorbentien.
NO875475D0 (no) Overflateaktive karbodiimider.
FI875790A0 (fi) Skyddade optiska blekmedel.
FI904584A0 (fi) Aktiv matrisvaetskekristalldisplay.
FI875738A (fi) Sialsyraderivat med aktiv karboxylgrupp.
DE3679956D1 (de) Optisch aktives tolanderivat.
FI875517A0 (fi) Optiska blekningsmedel innehaollande pappersbestrykningsmassor.
FI875217A (fi) Aktivt pansar.
DE3782973D1 (de) Laservorrichtung.
DE3785616D1 (de) Asphaerische einzellinse.
DE3776896D1 (de) Laseranordnung.
DE3785938D1 (de) Optisches system.
DE3779158D1 (de) Chrom-dotierter scandium-borat-laser.
FI871327A (fi) Ny optiskt aktiv foerening.
FI883755A0 (fi) Optisk minnesanordning.
DE3888440D1 (de) Optisch aktive 2-Biphenylpyridine.
FI883254A (fi) Cytostatiskt aktiva antracyklinderivat.
IT8660377V0 (it) Montapanna semplificato.
DE68921230D1 (de) Optisch-aktive Pyridylethanol-Derivate.
DE3770246D1 (de) Optisch aktive alkohole.
FI864046A0 (fi) Foerfarande foer framstaellning av en terapeutiskt aktiv foerening.
FI883754A (fi) Optisk minnesanordning.
FI882655A0 (fi) Optisk mottagare.
DE3771379D1 (de) Optisch aktive hydantoine.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: BYK GULDEN LOMBERG CHEMISCHE FABRIK